SmpB and tmRNA Orchestrate Purine Pathway for the Trimethoprim Resistance in Aeromonas veronii

Dan Wang, Hong Li, Wasi Ullah Khan, Xiang Ma, Hongqian Tang, Yanqiong Tang, Dongyi Huang, Zhu LiuFrontiers in Cellular and Infection Microbiology 2020 · DOI

TL;DR

This study reveals that the bacterial trans-translation system, composed of SmpB and tmRNA, plays a crucial role in Aeromonas veronii's resistance to the antibiotic trimethoprim by differentially regulating the purine metabolic pathway. Understanding these distinct roles offers potential new targets for combating multi-drug resistant bacteria.

What Problem Does This Paper Address?

Trimethoprim is a widely used antibiotic that targets bacterial DNA synthesis by inhibiting dihydrofolate reductase, a key enzyme in the folate pathway. However, bacteria can develop resistance to trimethoprim through various mechanisms, including alterations in purine metabolism and the activity of efflux pumps. While the trans-translation system (SmpB and tmRNA) is known for its role in protein quality control, its specific contribution to antibiotic resistance, particularly in the context of purine metabolism, remained unclear. This paper investigates how SmpB and tmRNA influence trimethoprim resistance in Aeromonas veronii, a significant aquatic and human pathogen, by dissecting their roles in the purine metabolic pathway.

Methods

The researchers employed a multi-pronged approach to investigate the roles of SmpB and tmRNA in trimethoprim resistance:

  • Genetic Manipulation: They created knockout strains of A. veronii for smpB and ssrA (tmRNA), as well as a double knockout strain (AsmpB_ssrA). Complementary strains were also generated to confirm the observed phenotypes were due to the specific gene deletions.
  • Minimum Inhibitory Concentration (MIC) Assays: Standard broth microdilution methods were used to determine the lowest concentration of trimethoprim that inhibited bacterial growth, both in standard media and in media supplemented with purine metabolites (adenosine, guanosine, ATP).
  • Transcriptomic Analysis: RNA sequencing (RNA-Seq) was performed on wild-type, AsmpB, and AssrA strains to analyze global gene expression changes, focusing on genes involved in purine metabolism and efflux pumps.
  • Metabolomic Analysis: Non-targeted metabolomics using UHPLC-QTOF-MS was employed to quantify the levels of various metabolites, particularly those in the purine pathway, in the different bacterial strains.
  • Efflux Pump Overexpression: To assess the role of efflux pumps, the acrA and acrB genes were overexpressed in the AssrA strain, and the resulting trimethoprim resistance was evaluated.

Datasets

Not discussed in the paper. The study utilized Aeromonas veronii strains isolated from diseased grass carp and E. coli WM3064 for cloning purposes. Transcriptomic data was deposited in the GEO accession number GSE120603. Metabolomic data was deposited at www.ebi.ac.uk/metabolights/MTBLS1411.

Key Insights and Ideas

  • Distinct Roles in Purine Metabolism: The most striking finding is that SmpB and tmRNA, while both involved in trans-translation, exert independent and non-interfering influences on different branches of the purine metabolic pathway. SmpB primarily impacts adenosine metabolism, leading to increased adenosine, AMP, and cAMP levels. In contrast, tmRNA (SmpB) is more involved in guanosine metabolism, resulting in elevated xanthine and guanosine.
  • Differential Trimethoprim Sensitivity: Deleting either smpB or ssrA individually increased trimethoprim sensitivity compared to the wild type. However, the double knockout (AsmpB_ssrA) showed even greater sensitivity, suggesting that while their roles are distinct, their combined absence has a synergistic effect on reducing resistance.
  • Efflux Pump Involvement: The ssrA deletion led to a downregulation of the acrA/acrB efflux pump genes, which are known to contribute to antibiotic resistance. Overexpressing these genes in the AssrA strain partially restored trimethoprim tolerance, highlighting the importance of efflux pumps in tmRNA-mediated resistance.
  • Purine Metabolites as Modulators: The addition of exogenous purine metabolites significantly affected trimethoprim tolerance. Specifically, excess adenosine made A. veronii more sensitive, while excess guanosine also reduced the MIC for the AssrA strain. This underscores the direct link between purine metabolite levels and trimethoprim resistance.
  • ATP's Complex Role: Interestingly, while ATP is a key purine metabolite, its addition (10mM) actually decreased trimethoprim MIC, suggesting that an overabundance of ATP might create a metabolic burden that indirectly affects resistance.

Key Results

  • The double knockout strain AsmpB_ssrA exhibited significantly decreased trimethoprim tolerance compared to the wild type.
  • AsmpB deletion led to a significant upregulation of adenosine metabolism-related enzymes and accumulation of adenosine, AMP, and cAMP.
  • AssrA deletion resulted in significant upregulation of hypoxanthine synthesis and guanosine metabolism enzymes, leading to increased xanthine.
  • AssrA deletion also caused significant downregulation of the efflux pump genes acrA/acrB.
  • Overexpression of acrA/acrB in the AssrA strain partially restored trimethoprim tolerance, with MIC values increasing from 2 µg/mL to 8 mg/mL in the presence of 1mM adenosine.
  • Supplementation with 1mM adenosine decreased the MIC of wild-type and AsmpB strains, while 1mM guanosine decreased the MIC of the AssrA strain.

Limitations and Future Work

  • Double Knockout vs. Single Knockouts: The paper notes that the reduced tolerance in the double knockout strain (AsmpB_ssrA) may be "less relevant to the function of the trans-translation system" itself, suggesting that the observed phenotypes might be influenced by other factors beyond the direct trans-translation role. Further investigation into these indirect effects would be beneficial.
  • ATP's Mechanism: The exact mechanism by which excess ATP reduces trimethoprim tolerance requires further elucidation. The authors speculate it might relate to the "one carbon unit synthesis," but this needs experimental validation.
  • Clinical Relevance: While the study suggests the trans-translation system as a potential target for clinical treatment, further research is needed to validate this in clinical settings and explore specific inhibitors or strategies.
  • Broader Applicability: The findings are specific to Aeromonas veronii. Investigating whether SmpB and tmRNA play similar roles in trimethoprim resistance in other multi-antibiotic resistant bacteria would be a valuable extension.

Summary updated

Abstract

Small protein B(SmpB) cooperates with transfer-messenger RNA (tmRNA) for <i>trans</i>-translation to ensure the quality control of protein synthesis in prokaryotes. Furthermore, they regulate cell metabolism separately. According to research, SmpB functions as a transcription factor, and tmRNA acts as a small RNA. Purine pathway has been reported to be related to trimethoprim resistance, including hypoxanthine synthesis, adenosine metabolism and guanosine metabolism. Another reason of drug tolerance is the efflux pump of the bacterium. In transcriptomic data, it was shown that the expression of some related enzymes in adenosine metabolism were raised significantly in <i>smpB</i> deletion strain than that of wild type, which led to the differential trimethoprim resistance of <i>Aeromonas veronii</i> (<i>A. veronii)</i>. Furthermore, the metabolic products of adenosine AMP, cAMP, and deoxyadenosine were accumulated significantly. However, the expressions of the enzymes related to hypoxanthine synthesis and guanosine metabolism were elevated significantly in <i>ssrA (small stable RNA, tmRNA) deletion strain</i>, which eventually caused an augmented metabolic product xanthine. In addition, the deletion of <i>ssrA</i> also affected the significant downregulations of efflux pump <i>acrA/acrB</i>. The minimal inhibitory concentrations (MIC) were overall decreased after the trimethoprim treatment to the wild type, Δ<i>smpB</i> and Δ<i>ssrA</i>. And the difference in sensitivity between Δ<i>smpB</i> and Δ<i>ssrA</i> was evident. The MIC of Δ<i>smpB</i> was descended significantly than those of wild type and Δ<i>ssrA</i> in M9 medium supplemented with 1 mM adenosine, illustrating that the adenosine metabolism pathway was principally influenced by SmpB. Likewise, the strain Δ<i>ssrA</i> conferred more sensitivity than wild type and Δ<i>smpB</i> in M9 medium supplemented with 1mM guanosine. By overexpressing <i>acrA</i>/<i>acrB</i>, the tolerance to trimethoprim was partially recovered in Δ<i>ssrA</i>. These results revealed that SmpB and tmRNA acted on different branches in purine metabolism, conferring the diverse trimethoprim resistance to <i>A. veronii</i>. This study suggests that the <i>trans</i>-translation system might be an effective target in clinical treatment of <i>A. veronii</i> and other multi-antibiotic resistance bacteria with trimethoprim.
BibTeX
@inproceedings{wang2020smpb,
  author = {Dan Wang and Hong Li and Wasi Ullah Khan and Xiang Ma and Hongqian Tang and Yanqiong Tang and Dongyi Huang and Zhu Liu},
  title = {{SmpB and tmRNA Orchestrate Purine Pathway for the Trimethoprim Resistance in Aeromonas veronii}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2020},
  doi = {10.3389/fcimb.2020.00239},
}
Figure